Iterum Therapeutics plc (ITRMF) › Capital ExpendituresIterum Therapeutics plc (ITRMF) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $812.0K2018: $90.0K2019: $24.0K2020: $11.0K2021: $61.0K2022: $62.0K2023: $13.0K2024: $2.0K$2.0K2017Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$2.0K-84.6%2023$13.0K-79.0%2022$62.0K+1.6%2021$61.0K+454.5%2020$11.0K-54.2%2019$24.0K-73.3%2018$90.0K-88.9%2017$812.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share